Research Article

The Prescription Pattern of Chinese Herbal Products Containing Ginseng among Tamoxifen-Treated Female Breast Cancer Survivors in Taiwan: A Population-Based Study

Table 1

Demographic characteristics and results of multiple logistic regression showing the adjusted odds ratios (aORs) and 95% CIs (confidence intervals) for tamoxifen-treated breast cancer survivors from the National Health Insurance Catastrophic Illnesses Registry of Taiwan who were followed up from 1998 to 2008.

CharacteristicsTamoxifen users who had ever used ginseng (%) Tamoxifen users who had never used TCMa (%)aORb
(95% CIc)

Number of cases13,50217,031
Number of endometrial cancers74107
Age at diagnosis of breast cancer
 Average50.1 ± 10.852.4 ± 11.8
 20~29 yrs193 (1.4)194 (1.1)1
 30~39 yrs1,896 (14.0)1,987 (11.7)0.87 (0.70–1.08)
 40~49 yrs5,099 (37.8)5,711 (33.5)0.81 (0.66–1.00)
 50~59 yrs3,551 (26.3)4,468 (26.2)0.75 (0.61–0.92)
 60~69 yrs2,005 (14.8)2,903 (17.0)0.65 (0.53–0.81)
 70~79 yrs758 (5.6)1,768 (10.4)0.43 (0.34–0.54)
Insured salary ($NT/month)
 02,337 (17.3)3,636 (21.3)1
 1–199997,160 (53.0)8,863 (52.0)1.12 (1.05–1.19)
 20000–399992,663 (19.7)3,081 (18.1)1.22 (1.13–1.32)
 >=400001,342 (9.9)1,451 (8.5)1.32 (1.20–1.45)
Insured region
 Northern Taiwan6,593 (48.8)9,766 (57.3)1
 Central Taiwan2,827 (20.9)2,375 (13.9)1.89 (1.77–2.01)
 Southern Taiwan3,643 (27.0)4,323 (25.4)1.28 (1.21–1.36)
 Eastern Taiwan287 (2.1)354 (2.1)1.23 (1.05–1.45)
 Outlying islands152 (1.1)215 (1.3)1.06 (0.86–1.32)
Duration of tamoxifen treatment
 <2 y6,524 (48.3)11,411 (67.0)1
 2–4 y5,908 (43.8)4,756 (27.9)2.15 (2.05–2.26)
 5–7 y983 (7.3)773 (4.5)2.20 (1.99–2.44)
 >=8 y87 (0.6)91 (0.5)1.69 (1.26–2.28)
Cancer treatment modalities
 Tamoxifen only190 (1.4)386 (2.3)1
 Tamoxifen and chemotherapy290 (2.1)777 (4.6)0.70 (0.56–0.87)
 Tamoxifen plus surgery3,514 (26.0)4,569 (26.8)1.21 (1.01–1.46)
 Tamoxifen, surgery, plus chemotherapy9,508 (70.4)11,299 (66.3)1.22 (1.02–1.47)

TCM refers to traditional Chinese medicine; bOR refers to odds ratio; cCI refers to confidence interval.